• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    What is Newborn Screening

    A few drops of blood are collected from the baby’s heel and put on a special filter paper. This paper is then sent to the Maryland State Health Department’s Newborn Screening Laboratory where the tests are performed. The few drops of blood are screened over 50 different conditions. These conditions include:
    Inability to break down different proteins
    Inability to break down different fats for energy

    Presence of abnormal red blood cells or sickle cell disease

    Abnormal thyroid function (congenital hypothyroidism)

    Abnormal adrenal glands (congenital adrenal hyperplasia)

    Cystic fibrosis
    Severe Combined Immunodeficiency Disorder (added in April 2016)
    Newborn Metabolic Screening is only a screening test and identifies babies that are “at risk” for potential problems. If your baby is identified as “at risk”, it does not mean your baby has the condition. It means your baby needs further testing to see if he or she has the condition. 
    If your baby’s Newborn Metabolic Screen results show he or she is “at risk”, the results are reported to the Newborn Screening Follow-up staff, a specially trained team of health care providers. A member of the follow-up staff will contact your baby’s doctor. If they cannot identify your baby’s doctor, the follow-up staff may call you directly to find out this information and to check on the baby.
    If your baby screens “at risk” for a possible condition he or she may look very healthy. The goal of newborn screening is to identify babies while they are still healthy and to get them early treatment to help prevent them from getting sick. Remember, most babies look healthy even if they have one of these conditions and most babies with these conditions do not have a family history of genetic problems.
    As noted previously, the Maryland newborn screening panel contains over 50 different conditions, but there are a few conditions that are not currently included on our panel.  These conditions, such as Krabbe Disease and other lysosomal storage disorders are very rare, but they can cause severe neurological problems or even death.  New treatments are being identified by specialists across the country which may help individuals with these conditions.  If you would like your baby screened for these supplemental conditions, you can talk to your baby’s primary care provider about obtaining this additional screening through another laboratory.  PerkinElmer Genetics offers this screening, as well as Mayo Medical Laboratories.  Other laboratories may also offer this screening.  In addition to talking to your baby’s provider, you can also directly purchase a screening kit through Hunter's Hope for a discounted price.  The Hunter’s Hope website also has a lot of information for you on Krabbe and other lysosomal storage disorders. 
    For information on Newborn Metabolic Screening regulations in Maryland, click here.